NR3C2 and diabetes mellitus: The protective effect of MR antagonist finerenone for the renal function of patients with diabetes mellitus and pre-damaged kidneys has been demonstrated by multi-center studies such as FIDELIO-DKD and FIGARO-DKD [9,10].